Oramed Pharm - is a clinical stage biopharmaceutical company. 2022/3 Planned launch of MesenCure multinational phase III clinical trial; and phase II/III clinical trial in the US evaluating the safety and efficacy of BonoFillTM injectable live bone graft for bone regeneration.
Bonds are at a long term trendline and may be signaling a rush into bonds in months ahead. This makes me approach equities very cautiously right now. $TLT
Last couple of times we have had this tight spread between US05Y and US02Y a mayor decline in the S&P followed Before the declines, we saw some increase in volatility. The same kind of volatility happened last year. Could we see a mayor decline, or a correction this year, or will the S&P just keep moving up? Global growth forecast have been slashed across the...